InvestorsHub Logo
Followers 46
Posts 1658
Boards Moderated 0
Alias Born 09/01/2013

Re: None

Wednesday, 11/02/2016 12:25:09 PM

Wednesday, November 02, 2016 12:25:09 PM

Post# of 977
Cowen “we believe TRIL has identified a therapeutic dose that is both well tolerated and immunologically active” #BestInClass